New Delhi: Kovacin’s vaccine has been approved by the Drug Administration of India for use by people over 12 years of age.
The 2nd vaccine is approved for use in those under 18 years of age. Prior to this, Zygov-D was licensed by Zydos Kedala, and now Kovacsin is licensed.
The Drug Administration of India has approved two doses of covaxin at 4-week intervals.
Last August the Zygote Kedila vaccine Zygov-T was used for emergencies in people over 12 years of age. DCGI Granted permission. Zydus Ketila said it could produce one million vaccines a month.
Covaxin in this regard Vaccine In a statement, Bharat Biotech said, “Kovacsin Vaccine Made uniquely. Alone for adults and alone for children Vaccine Has been created. Covaxin Vaccine It has proven to be safe and effective for all categories. We hope that the Kovac vaccine will provide the same protection for children as it does for adults. ”
Krishna Ella, Managing Director, Bharat Biotech, said: Vaccine The experiment was completed by paying 1000 to volunteers aged 2 to 18 years. Its figures have also been forwarded to the DCGA. ”
Although Bharat Biotech has sent statistics to people between the ages of 2 and 18, Kovacs is only available to those aged 12 and over. Vaccine Permission granted to use.
The first dose is given to 89% of the adult population in India Vaccine Has been paid. There are 40 crore people under the age of 18 alone.
.
